Clot formation
The beginning of the coagulation response and the early development of clot mechanics.
Science
Read the whole coagulation story faster.
CoagCare's public materials describe a viscoelastic approach intended to follow blood from clot initiation through peak clot strength and fibrinolysis in a compact point-of-care format.
Medical research imagery from Pexels.
Viscoelastic concept
A continuous view instead of a single moment.
What the platform measures
Three stages, one visual narrative.
The design uses a simplified curve to explain concepts already present in Abram's public materials without inventing clinical thresholds or diagnostic values.
Clot strength
Public descriptions emphasize measurement of viscoelastic properties as clot structure develops.
Fibrinolysis
The curve continues through clot breakdown rather than stopping at a single endpoint.
Public development milestones
A research path built over years.
2018
NSF Phase I
Early SBIR work centered on a portable platform for multiple blood clotting measurements.
2021
NSF Phase II
Follow-on development continued the portable point-of-care implementation.
2026
DARPA / DOW Phase II
Award work describes further miniaturization for field-deployable trauma and hemorrhage use.
2026
Clinical milestones
The company announced new financing to advance development and work toward FDA 510(k) clearance.
Regulatory clarity
Development-stage technology deserves clear language.
Throughout this concept, product descriptions are framed as design goals and publicly reported capabilities, not as independent clinical claims.